Bio-Rad Laboratories Class A
498 hedge funds and large institutions have $9.18B invested in Bio-Rad Laboratories Class A in 2022 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 159 increasing their positions, 200 reducing their positions, and 70 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
14% less capital invested
Capital invested by funds: $10.7B → $9.18B (-$1.55B)
21% less repeat investments, than reductions
Existing positions increased: 159 | Existing positions reduced: 200
63% less call options, than puts
Call options by funds: $41.9M | Put options by funds: $115M
Holders
498
Holding in Top 10
8
Calls
$41.9M
Puts
$115M
Top Buyers
| 1 | +$380M | |
| 2 | +$70.7M | |
| 3 | +$47.9M | |
| 4 |
Millennium Management
New York
|
+$44.3M |
| 5 |
NC
Nitorum Capital
New York
|
+$38.6M |
Top Sellers
| 1 | -$120M | |
| 2 | -$112M | |
| 3 | -$108M | |
| 4 |
BlackRock
New York
|
-$83.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$41.6M |